In two-marker models, such as the combination of plasma human epididymis secretory protein 4 (HE4) and miR-127-3p, the expression of plasma miR-127-3p in breast cancer patients was significantly higher than that in benign breast tumors and healthy controls (both p < 0.001) [83]. This evidence concerns the gene WFDC2 and breast carcinoma.